BNP Paribas Financial Markets
IMGN

BNP Paribas Financial Markets’s Immunogen Inc IMGN Stock Holding History

BNP Paribas Financial Markets’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-137,098
Closed -$4.06M – 4305
2023
Q4 		$4.06M Sell
137,098
-98,984
-42% -$1.97M ﹤0.01% 1545
2023
Q3 		$3.75M Sell
236,082
-142,409
-38% -$2.37M ﹤0.01% 1466
2023
Q2 		$7.14M Sell
378,491
-159,211
-30% -$1.88M 0.01% 1059
2023
Q1 		$2.06M Buy
537,702
+174,138
+48% +$742K ﹤0.01% 1788
2022
Q4 		$1.8M Buy
363,564
+19,324
+6% +$105K ﹤0.01% 1828
2022
Q3 		$1.65M Buy
344,240
+281,816
+451% +$1.49M ﹤0.01% 2104
2022
Q2 		$281K Buy
62,424
+30,981
+99% +$135K ﹤0.01% 2943
2022
Q1 		$150K Sell
31,443
-30,118
-49% -$167K ﹤0.01% 3223
2021
Q4 		$457K Buy
61,561
+2,406
+4% +$15K ﹤0.01% 3047
2021
Q3 		$335K Buy
59,155
+33,005
+126% +$191K ﹤0.01% 2891
2021
Q2 		$172K Sell
26,150
-52,246
-67% -$364K ﹤0.01% 2907
2021
Q1 		$635K Buy
78,396
+55,804
+247% +$456K ﹤0.01% 2431
2020
Q4 		$146K Sell
22,592
-17,859
-44% -$104K ﹤0.01% 3028
2020
Q3 		$146K Buy
40,451
+20,055
+98% +$81K ﹤0.01% 2906
2020
Q2 		$93.8K Sell
20,396
-59,026
-74% -$251K ﹤0.01% 2792
2020
Q1 		$271K Buy
79,422
+56,528
+247% +$247K ﹤0.01% 2698
2019
Q4 		$117K Sell
22,894
-25
-0.1% -$85 ﹤0.01% 3217
2019
Q3 		$55.5K Buy
22,919
+7,064
+45% +$18.8K ﹤0.01% 3418
2019
Q2 		$34.4K Sell
15,855
-14,013
-47% -$33.1K ﹤0.01% 3650
2019
Q1 		$80.9K Buy
29,868
+29,830
+78,500% +$129K ﹤0.01% 3249
2018
Q4 		$182 Sell
38
-4,185
-99% -$25.4K ﹤0.01% 4109
2018
Q3 		$40K Hold
4,223
– – ﹤0.01% 3138
2018
Q2 		$41.1K Sell
4,223
-16,383
-80% -$173K ﹤0.01% 3203
2018
Q1 		$217K Buy
20,606
+100
+0.5% +$988 ﹤0.01% 2751
2017
Q4 		$131K Buy
20,506
+11,475
+127% +$70.8K ﹤0.01% 3161
2017
Q3 		$69.1K Sell
9,031
-609
-6% -$4.05K ﹤0.01% 2973
2017
Q2 		$68.5K Buy
9,640
+8,956
+1,309% +$41K ﹤0.01% 3018
2017
Q1 		$2.65K Sell
684
-4,329
-86% -$12.6K ﹤0.01% 3460
2016
Q4 		$10.2K Sell
5,013
-1,876
-27% -$3.77K ﹤0.01% 3448
2016
Q3 		$18.5K Buy
6,889
+3,605
+110% +$10.5K ﹤0.01% 2937
2016
Q2 		$10.1K Buy
3,284
+2,411
+276% +$15.1K ﹤0.01% 2910
2016
Q1 		$7.44K Sell
873
-21,315
-96% -$180K ﹤0.01% 2245
2015
Q4 		$301K Buy
22,188
+2,491
+13% +$30.7K ﹤0.01% 1668
2015
Q3 		$189K Buy
19,697
+10,588
+116% +$155K ﹤0.01% 1994
2015
Q2 		$131K Buy
9,109
+5,115
+128% +$56.2K ﹤0.01% 1938
2015
Q1 		$35.7K Buy
3,994
+2,055
+106% +$14.9K ﹤0.01% 2090
2014
Q4 		$11.8K Sell
1,939
-3,579
-65% -$32.7K ﹤0.01% 1782
2014
Q3 		$58.4K Buy
5,518
+5,419
+5,474% +$61.3K ﹤0.01% 2502
2014
Q2 		$1.17K Buy
99
+58
+141% +$728 ﹤0.01% 3378
2014
Q1 		$531 Sell
41
-1,056
-96% -$16.6K ﹤0.01% 3029
2013
Q4 		$16.1K Sell
1,097
-22,199
-95% -$341K ﹤0.01% 2351
2013
Q3 		$396K Sell
23,296
-6,194
-21% -$109K ﹤0.01% 1717
2013
Q2 		$489K Buy
+29,490
New +$478K ﹤0.01% 1576

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BNP Paribas Financial Markets's IMGN Position: Q1 2024 in Review

BNP Paribas Financial Markets sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 137,098 shares — an estimated $4.06M sold.

BNP Paribas Financial Markets first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $7.14M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • BNP Paribas Financial Markets reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 137,098 Immunogen Inc shares in Q1 2024, an estimated $4.06M.
  • BNP Paribas Financial Markets first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • BNP Paribas Financial Markets's Immunogen Inc position peaked at $7.14M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2024, filed 1 May 2024.